0001209191-22-048473.txt : 20220902 0001209191-22-048473.hdr.sgml : 20220902 20220902160532 ACCESSION NUMBER: 0001209191-22-048473 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220901 FILED AS OF DATE: 20220902 DATE AS OF CHANGE: 20220902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Henderson Molly CENTRAL INDEX KEY: 0001363812 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39094 FILM NUMBER: 221225082 MAIL ADDRESS: STREET 1: 305 COLLEGE ROAD EAST CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Phathom Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001783183 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824151574 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CAMPUS DRIVE, STREET 2: SUITE 102 CITY: FLORHAM PARK STATE: NJ ZIP: 07932 BUSINESS PHONE: (877) 742-8466 MAIL ADDRESS: STREET 1: 100 CAMPUS DRIVE, STREET 2: SUITE 102 CITY: FLORHAM PARK STATE: NJ ZIP: 07932 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-09-01 0 0001783183 Phathom Pharmaceuticals, Inc. PHAT 0001363812 Henderson Molly C/O PHATHOM PHARMACEUTICALS, INC. 100 CAMPUS DRIVE, SUITE 102 FLORHAM NJ 07932 0 1 0 0 CFO and CBO Common Stock 2022-09-01 4 A 0 7500 0.00 A 45500 D Common Stock 338.86 I By 401(k) Represents restricted stock units ("RSUs") granted on September 1, 2022. Fifty percent (50%) of the total number of RSUs granted vest on each of March 1, 2023 and June 1, 2023, subject to the Reporting Person's continued service on each applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer. Includes 338.86 shares acquired under the Phathom Pharmaceuticals, Inc. 401(k) plan. /s/ Larry Miller, Attorney-in-Fact for Molly Henderson 2022-09-02